Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen and nitrogen species (RONS) are a diverse group of highly reactive molecules, including free radicals like superoxide and hydroxyl radicals, as well as non-radicals like hydrogen peroxide and peroxynitrite. They are produced as natural byproducts of aerobic metabolism and play critical roles in cell signaling and the immune response, particularly during the oxidative burst used by phagocytes to destroy pathogens (NIH, 2022). Oxidized thiols refer to the modification of cysteine residues within proteins, which can act as redox switches to regulate enzymatic activity and structural integrity (PubMed, 2021). When the production of RONS exceeds the capacity of cellular antioxidant defenses, a state of oxidative stress occurs, leading to the damage of lipids, proteins, and DNA. This damage is a hallmark of numerous pathologies, including neurodegenerative diseases like Alzheimer's and various cardiovascular conditions (StatPearls, 2023). Therapeutic intervention typically involves the use of antioxidants or scavengers that directly interact with these species to neutralize them or reduce oxidized protein thiols back to their functional states. However, because RONS are also vital for normal physiological signaling, non-specific targeting remains a significant challenge in drug development.
Direct scavenging of free radicals, neutralization of reactive oxygen/nitrogen intermediates, and reduction of oxidized cysteine thiol groups to restore cellular redox balance.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen and nitrogen species and oxidized thiols (RONS).